Rodney Pena
Psychiatric/Mental Health · Hazel Crest, ILNPI 1750989620
Payments from drug & device makers
Across 98 payments — averaging $20.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$595
- Axsome Therapeutics, Inc.$276
- Johnson & Johnson$204
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$140
- Otsuka America Pharmaceutical, Inc.$128
- Alkermes, Inc.$126
- plus $577 from 7 others
What the payments were for
- Food & beverage$2,046100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $595 |
| Axsome Therapeutics, Inc. | 8 | $276 |
| Johnson & Johnson | 6 | $204 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $140 |
| Otsuka America Pharmaceutical, Inc. | 7 | $128 |
| Alkermes, Inc. | 7 | $126 |
| Teva Pharmaceuticals USA, Inc. | 6 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $101 |
| Neurocrine Biosciences, Inc. | 5 | $96 |
| Lundbeck LLC | 5 | $94 |
| Idorsia Pharmaceuticals US Inc | 4 | $73 |
| Corium, LLC | 4 | $72 |
| Sunovion Pharmaceuticals Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,046 in reported general payments places this provider in the 80th percentile of 922 psychiatric/mental health providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 25 | $1,252 |
| Trazodone Hcl | 45 | $541 |
| Duloxetine Hcl | 28 | $449 |
| Buspirone Hcl | 44 | $411 |
| Bupropion XlBupropion Hcl | 31 | $368 |
| Fluvoxamine Maleate | 11 | $363 |
| Escitalopram Oxalate | 47 | $287 |
| Alprazolam | 45 | $282 |
| Olanzapine | 12 | $269 |
| Clonazepam | 14 | $142 |
| Prazosin Hcl | 12 | $135 |
| Lamotrigine | 13 | $110 |
| Sertraline Hcl | 20 | $106 |
| Lorazepam | 12 | $29 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Hazel Crest
- Erin PetrusicChicago$517K
- Maurice BrownleeChicago$162K
- Melissa VitaleChicago$151K
- Alan AmbergChicago$119K
- Jaime MendozaMaryville$111K
- Jennifer TheryMaryville$83K
- Carole Weddington HuntGranite City$67K
- Jessica WhelanBloomington$55K
- Lynn LochnerKankakee$41K
- Julie CarbrayChicago$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.